IRIS - Res&Arch Institutional Research Information System - Research & Archive

TABARRINI, Oriana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.168
NA - Nord America 5.790
EU - Europa 4.628
SA - Sud America 567
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 17.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.699
CN - Cina 2.783
SG - Singapore 1.626
IT - Italia 871
IE - Irlanda 768
UA - Ucraina 692
VN - Vietnam 644
HK - Hong Kong 603
SE - Svezia 592
RU - Federazione Russa 500
BR - Brasile 491
DE - Germania 342
FI - Finlandia 241
KR - Corea 177
GB - Regno Unito 141
BE - Belgio 106
PL - Polonia 73
TR - Turchia 60
FR - Francia 58
IN - India 58
JP - Giappone 49
AT - Austria 47
CA - Canada 46
RO - Romania 41
NL - Olanda 38
AR - Argentina 35
MX - Messico 35
BD - Bangladesh 34
ES - Italia 29
CH - Svizzera 28
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
ZA - Sudafrica 17
PK - Pakistan 16
CI - Costa d'Avorio 14
ID - Indonesia 14
IQ - Iraq 11
EC - Ecuador 10
AE - Emirati Arabi Uniti 9
IR - Iran 8
LB - Libano 8
PY - Paraguay 8
SA - Arabia Saudita 8
CL - Cile 7
GR - Grecia 7
IL - Israele 7
KE - Kenya 6
LT - Lituania 6
EG - Egitto 5
MA - Marocco 5
CO - Colombia 4
DO - Repubblica Dominicana 4
EU - Europa 4
LV - Lettonia 4
PE - Perù 4
BG - Bulgaria 3
BH - Bahrain 3
JO - Giordania 3
LK - Sri Lanka 3
OM - Oman 3
UY - Uruguay 3
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
TN - Tunisia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CV - Capo Verde 1
DM - Dominica 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
TW - Taiwan 1
Totale 17.214
Salva come PNG Salva come JPEG
Città #
Guangzhou 2.083
Singapore 1.083
Chandler 1.002
Dublin 768
Hong Kong 591
Dong Ket 503
Perugia 503
San Mateo 414
Jacksonville 356
Boardman 278
Ashburn 270
Santa Clara 238
Beijing 180
Medford 177
Princeton 176
Seoul 174
Ann Arbor 146
Wilmington 134
Altamura 125
Lawrence 111
Moscow 107
Brussels 106
Munich 104
Los Angeles 99
Andover 95
New York 72
Piscataway 72
Fremont 66
Ho Chi Minh City 64
The Dalles 60
West Jordan 58
São Paulo 53
Des Moines 47
Saint Petersburg 47
Warsaw 47
Turku 46
Tokyo 44
Redmond 43
Helsinki 42
Nanjing 40
Norwalk 34
Dallas 32
Vienna 32
Brooklyn 31
Woodbridge 31
Atlanta 30
Izmir 30
Hanoi 26
Bucharest 25
Hefei 25
Chicago 22
San Paolo di Civitate 21
Chennai 20
Dearborn 20
Denver 20
Rio de Janeiro 20
Redwood City 19
Falls Church 18
Montreal 18
Ankara 17
Columbus 16
Phoenix 16
Poplar 16
Rome 16
Spoleto 16
Stockholm 16
Shanghai 15
Abidjan 14
Houston 14
Orem 14
San Diego 14
Secaucus 14
Chongqing 13
Dhaka 13
London 13
Nuremberg 13
Philadelphia 13
Hanover 12
Johannesburg 12
Porto Alegre 12
Den Haag 11
Manchester 11
Mexico City 11
Olomouc 11
San Jose 11
Seattle 11
Toronto 11
Belo Horizonte 10
Charlotte 10
San Francisco 10
Timisoara 10
Amsterdam 9
Auburn Hills 9
Bologna 9
Council Bluffs 9
Milan 9
Boston 8
Brasília 8
Buffalo 8
Changsha 8
Totale 11.591
Salva come PNG Salva come JPEG
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.124
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 305
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 298
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 287
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 285
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 229
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 171
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 151
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 144
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 135
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 130
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 124
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 124
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 120
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 118
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 116
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 115
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 114
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 111
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 110
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 110
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 108
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 108
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 108
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 108
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 106
6-Aminoquinolones as New Potential Anti-HIV Agents 105
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 105
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 105
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 104
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 104
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 104
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 103
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 103
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 103
6-Desfluoroquinolones as promising HIV transcription inhibitors 102
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 102
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 101
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 100
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 100
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 98
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 97
A New Derivative with Ultra-Potent Anti-HIV Activity 97
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 97
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 96
A new 6-aminoquinolone compound with anti-HCMV activity 95
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 95
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 94
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 94
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 94
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 93
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 93
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 93
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 92
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 91
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors. 90
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 90
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 90
QSAR study and VolSurf characterization of anti-HIV quinolone library 89
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 89
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 89
S. aureus NorA efflux pump: the discovery of new potent inhibitors 89
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 88
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 87
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 87
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 87
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 87
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 86
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 86
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 85
6-Hydroxy Derivative as New Desfluoroquinolone (DFQ): Synthesis and DNA-binding Study 85
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 85
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 85
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 84
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 84
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 84
In Vitro Activities of New Quinolones Against Helicobacter pylori 83
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 83
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 83
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 83
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 82
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 82
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 82
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 82
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 82
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 80
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 80
Nuovi Tiopiranopiridinil Chinoloni 79
Antiviral 6-aminoquinolones: Molecolar basis for potency and selectivity. 79
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 79
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 78
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 78
New compounds targeting the rna polymerase of influenza a and b viruses. 77
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 75
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 74
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 74
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 74
Symbiotic approach to drug design: N-[(4-chloro-3-sulfamoylbenzamido)-ethyl]propanolamine derivatives as β-adrenergic blocking agents with diuretic activity 71
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 71
Design and Synthesis of Modified Quinolones as Antitumoral Acridones 70
Totale 12.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.173 0 0 0 0 0 127 160 11 169 65 109 532
2021/20221.733 52 301 36 112 116 11 32 488 89 51 211 234
2022/20232.873 199 482 37 268 266 304 3 171 1.001 21 87 34
2023/20243.324 69 191 67 30 20 29 2.333 28 137 88 148 184
2024/20253.157 35 270 115 261 367 163 292 182 544 196 483 249
2025/20263.054 426 446 322 834 835 191 0 0 0 0 0 0
Totale 17.760